The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 05, 2014
Filed:
Oct. 08, 2010
Melissa Dumble, Piscataway, NJ (US);
Tona Gilmer, Research Triangle Park, NC (US);
Rakesh Kumar, Collegeville, PA (US);
Peter F. Lebowitz, Collegeville, PA (US);
Shannon Renae Morris, Research Triangle Park, NC (US);
Sylvie Laquerre, Collegeville, PA (US);
Melissa Dumble, Piscataway, NJ (US);
Tona Gilmer, Research Triangle Park, NC (US);
Rakesh Kumar, Collegeville, PA (US);
Peter F. Lebowitz, Collegeville, PA (US);
Shannon Renae Morris, Research Triangle Park, NC (US);
Sylvie Laquerre, Collegeville, PA (US);
GlaxoSmithKline LLC, Wilmington, DE (US);
Abstract
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof.